Ortho-Clinical Diagnostics, Inc. today announced that it obtained CE Mark (Conformité Européenne) for the VITROS ® Chemistry Products HbA1c Reagent Kit, an enhanced assay to detect and monitor blood ...
Operational, performance and clinical improvements without having results interfered by common hemoglobin variants demonstrate company commitment to meet evolving customer needs Ortho Clinical ...
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration ("FDA") has granted QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, 510(k ...
QuidelOrtho Corporation (QuidelOrtho), a global leader of in vitro diagnostics, announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its VITROS hs Troponin I ...
- Operational, performance and clinical improvements highlight company commitment to deliver new product offerings to meet evolving customer needs - Ortho-Clinical Diagnostics, Inc. today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback